VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 23 · 115th Congress

Biological Implant Tracking and Veteran Safety Act of 2017

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

1 cosponsor · 1 D

0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill directs the Department of Veterans Affairs (VA) to:

What it does: CRS summary · Introduced in Senate · Jan 4, 2017

Biological Implant Tracking and Veteran Safety Act of 2017

This bill directs the Department of Veterans Affairs (VA) to:

  • adopt the unique device identification system developed for medical devices by the Food and Drug Administration (FDA), or implement a comparable standard identification system, for identifying biological implants intended for use in VA medical facilities;
  • permit a vendor to use any of the accredited entities identified by the FDA as an issuing agency;
  • implement (within 180 days after enactment of this bill) a compatible system for tracking implants from human donor or animal source to implantation; and
  • implement compatible inventory controls so that patients who have received a biological implant in a VA medical facility subject to FDA recall can be appropriately notified.

The bill prescribes requirements for vendors from which the VA may procure biological implants of human and non-human origin.

The VA shall: (1) procure such implants under General Services Administration Federal Supply Schedules unless they are not available under such Schedules, (2) accommodate reasonable vendor requests to undertake specified outreach efforts to educate VA medical professionals about the use and efficacy of implants, and (3) procure biological implants that are unavailable under such Schedules using competitive procedures in accordance with the Federal Acquisition Regulation.

Certain biological implants may be temporarily procured by the VA without relabeling under the standard identification system.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Biological Implant Tracking and Veteran Safety Act of 2017

Latest action (May 17, 2017): Committee on Veterans' Affairs. Hearings held. Hearings printed: S.Hrg. 115-299.

Policy area: Armed Forces and National Security · Origin: Senate · Introduced: Jan 4, 2017

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.